Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Protandim to Asia

This article was originally published in The Tan Sheet

Executive Summary

NutraNomics will market and distribute Greenwood Village, Colo.-based natural products firm LifeVantage's dietary supplement Protandim in Asian markets, LifeVantage says. "NutraNomics has an excellent reputation as an organization that is known for its ability to quickly achieve successful product launches in Asia," says LifeVantage President and CEO David Brown. NutraNomics CEO Tracy Gibbs says the Sandy, Utah-based firm's experience will help to "effectively represent and distribute Protandim throughout our vast network in Asia"..

You may also be interested in...



Henlius Partners With Mabxience On Trastuzumab

Henlius has struck a deal with Mabxience to market its HLX02 trastuzumab biosimilar in Argentina, Uruguay and Paraguay.

European Parliament To Vote On MDR Delay As Council Rectifies Critical Mistake

The EU is pulling out all the stops to have the one-year delay to the MDR adopted before it is too late, and a crucial vote will take place on 16 April.

Coronavirus Update: FDA Fast-Tracks Blood Plasma Trials, Novavax Closes In On Vaccine Start

As US cases set to reach half a million, FDA gives green light to blood plasma trials to help meet urgent need for therapies.

Topics

UsernamePublicRestriction

Register

PS101379

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel